PMID,Title,Journal,Year
39796706,Differential Effects of GLP-1 Receptor Agonists on Cancer Risk in Obesity: A Nationwide Analysis of 1.1 Million Patients.,Cancers,2024
38313829,The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer.,"Endocrine oncology (Bristol, England)",2024
38127407,Exploring the potential impact of GLP-1 receptor agonists in cancer therapy.,Minerva endocrinology,2023
33957171,Liraglutide treatment counteracts alterations in adipose tissue metabolism induced by orchiectomy in rats.,Life sciences,2021
32283060,"Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line.",European journal of pharmacology,2020
29898902,Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial.,Diabetes care,2018
28008585,Glucagon-like Peptide-1 Analogues Inhibit Proliferation and Increase Apoptosis of Human Prostate Cancer Cells in vitro.,"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association",2017
27633684,Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients.,Current medicinal chemistry,2016
23375875,Incretin-based therapies in the treatment of type 2 diabetes--more than meets the eye?,European journal of internal medicine,2013
